InsiderTrades

Form 4 for SYK Stryker Corporation

Accepted 2024-11-08 00:00:00 ET · period of report 2024-11-07 · accession 0000310764-24-000118 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-11-08 2024-11-07 SYK Lobo Kevin COB, CEO, Dir S - Sale+OE $368.70 -57.3K 115.9K -33% -$21.13M
D 2024-11-08 2024-11-07 SYK Lobo Kevin COB, CEO, Dir M - OptEx $93.06 +156.9K 256.9K +157% +$14.60M
D 2024-11-08 2024-11-07 SYK Lobo Kevin COB, CEO, Dir F - Tax $369.02 -99.6K 157.3K -39% -$36.75M
D 2024-11-08 2024-11-07 SYK Lobo Kevin COB, CEO, Dir M - OptEx $0.00 -156.9K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-11-07 S D 15,866 $369.75 100,027 D — — (F4) The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $369.27 to $370.20, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
2 Common Common Stock 2024-11-07 M A 156,890 $93.06 256,917 D — — (F1) Includes 2,685 shares of Stryker Common Stock acquired pursuant to Stryker Corporation's Employee Stock Purchase Plan ("ESPP") as of September 30, 2024, the date of the latest available statement of the reporting person's ESPP holdings.
3 Common Common Stock 2024-11-07 S D 18,269 $367.95 139,071 D — — (F2) The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $367.38 to $368.19, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
4 Common Common Stock 2024-11-07 F D 99,577 $369.02 157,340 D — —
5 Common Common Stock 2024-11-07 S D 23,178 $368.58 115,893 D — — (F3) The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $368.21 to $369.20, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
6 Derivative Employee Stock Option granted 2/11/2015 (right to buy) 2024-11-07 M D 156,890 $0.00 0 D $93.06 · — to 2025-02-10 156,890 Common Stock (F5) Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant.